Jauniaux Eric, Collins Sally L, Jurkovic Davor, Burton Graham J
Department of Obstetrics and Gynecology, University College London Hospitals and University College London Institute for Women's Health, University College London, London, United Kingdom.
Nuffield Department of Obstetrics and Gynecology, University of Oxford, and the Fetal Medicine Unit, John Radcliffe Hospital, Oxford, United Kingdom.
Am J Obstet Gynecol. 2016 Dec;215(6):712-721. doi: 10.1016/j.ajog.2016.07.044. Epub 2016 Jul 26.
Determining the depth of villous invasiveness before delivery is pivotal in planning individual management of placenta accreta. We have evaluated the value of various ultrasound signs proposed in the international literature for the prenatal diagnosis of accreta placentation and assessment of the depth of villous invasiveness.
We undertook a PubMed and MEDLINE search of the relevant studies published from the first prenatal ultrasound description of placenta accreta in 1982 through March 30, 2016, using key words "placenta accreta," "placenta increta," "placenta percreta," "abnormally invasive placenta," "morbidly adherent placenta," and "placenta adhesive disorder" as related to "sonography," "ultrasound diagnosis," "prenatal diagnosis," "gray-scale imaging," "3-dimensional ultrasound", and "color Doppler imaging."
The primary eligibility criteria were articles that correlated prenatal ultrasound imaging with pregnancy outcome. A total of 84 studies, including 31 case reports describing 38 cases of placenta accreta and 53 series describing 1078 cases were analyzed. Placenta accreta was subdivided into placenta creta to describe superficially adherent placentation and placenta increta and placenta percreta to describe invasive placentation.
Of the 53 study series, 23 did not provide data on the depth of villous myometrial invasion on ultrasound imaging or at delivery. Detailed correlations between ultrasound findings and placenta accreta grading were found in 72 cases. A loss of clear zone (62.1%) and the presence of bridging vessels (71.4%) were the most common ultrasound signs in cases of placenta creta. In placenta increta, a loss of clear zone (84.6%) and subplacental hypervascularity (60%) were the most common ultrasound signs, whereas placental lacunae (82.4%) and subplacental hypervascularity (54.5%) were the most common ultrasound signs in placenta percreta. No ultrasound sign or a combination of ultrasound signs were specific of the depth of accreta placentation.
The wide heterogeneity in terminology used to describe the grades of accreta placentation and differences in study design limits the evaluation of the accuracy of ultrasound imaging in the screening and diagnosis of placenta accreta. This review emphasizes the need for further prospective studies using a standardized evidence-based approach including a systematic correlation between ultrasound signs of placenta accreta and detailed clinical and pathologic examinations at delivery.
在分娩前确定绒毛侵入深度对于制定胎盘植入的个体化管理方案至关重要。我们评估了国际文献中提出的各种超声征象在产前诊断植入性胎盘和评估绒毛侵入深度方面的价值。
我们在PubMed和MEDLINE数据库中检索了1982年首次对胎盘植入进行产前超声描述至2016年3月30日期间发表的相关研究,使用关键词“胎盘植入”“穿透性胎盘植入”“胎盘植入异常”“病态粘连胎盘”“胎盘粘连障碍”,并与“超声检查”“超声诊断”“产前诊断”“灰阶成像”“三维超声”及“彩色多普勒成像”相关联。
主要纳入标准为将产前超声成像与妊娠结局相关联的文章。共分析了84项研究,包括31篇病例报告(描述38例胎盘植入)和53篇系列研究(描述1078例)。胎盘植入被细分为胎盘粘连以描述表浅粘连性胎盘植入,以及穿透性胎盘植入和植入性胎盘植入以描述侵入性胎盘植入。
在53项系列研究中,23项未提供超声成像或分娩时绒毛肌层侵入深度的数据。在72例病例中发现了超声检查结果与胎盘植入分级之间的详细关联。胎盘粘连病例中,最常见的超声征象是清晰区消失(62.1%)和桥接血管的存在(71.4%)。在植入性胎盘植入中,清晰区消失(84.6%)和胎盘下血管增多(60%)是最常见的超声征象,而胎盘腔隙(82.4%)和胎盘下血管增多(54.5%)是穿透性胎盘植入中最常见的超声征象。没有单一的超声征象或超声征象组合对植入性胎盘的深度具有特异性。
用于描述植入性胎盘分级的术语存在广泛异质性以及研究设计的差异,限制了超声成像在胎盘植入筛查和诊断中的准确性评估。本综述强调需要进一步开展前瞻性研究,采用标准化的循证方法,包括胎盘植入超声征象与分娩时详细临床和病理检查之间的系统关联。